GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,000 | -12.5% | 30 | -58.9% | 0.00% | -50.0% |
| Q4 2020 | $8,000 | -27.3% | 73 | -35.4% | 0.00% | -33.3% |
| Q3 2020 | $11,000 | -21.4% | 113 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $14,000 | +40.0% | 113 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $10,000 | -16.7% | 113 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | -20.0% | 113 | -11.7% | 0.00% | -25.0% |
| Q3 2019 | $15,000 | -48.3% | 128 | -23.8% | 0.00% | -42.9% |
| Q2 2019 | $29,000 | +3.6% | 168 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $28,000 | +75.0% | 168 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $16,000 | -75.0% | 168 | -54.6% | 0.00% | -69.2% |
| Q3 2018 | $64,000 | +14.3% | 370 | -7.5% | 0.01% | 0.0% |
| Q2 2018 | $56,000 | +24.4% | 400 | 0.0% | 0.01% | +30.0% |
| Q1 2018 | $45,000 | -15.1% | 400 | 0.0% | 0.01% | -23.1% |
| Q4 2017 | $53,000 | +65.6% | 400 | +27.0% | 0.01% | +62.5% |
| Q3 2017 | $32,000 | 0.0% | 315 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $32,000 | – | 315 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |